Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2021

View Archived Issues

Overcoming EGFR-targeted TKI lung cancer resistance

Sulfopin, a new selective Pin1 inhibitor with in vivo anticancer activity in Myc-driven tumors

Engineered microbial therapy for local metabolic modulation of the tumor microenvironment

AMPK is a therapeutic target in PDAC

BDNF and NSE as biomarkers in alcohol use disorder and mood disorder comorbidity

New EGFR inhibitors identified at PharmaBlock Sciences

Heptares Therapeutics describes new GLP-1 and GLP-2 receptor agonists

LG Chem discovers GLP-1 receptor agonists

Beijing Jacobio Pharmaceuticals patents KRAS mutant protein inhibitors

New adenosine receptor antagonists synthesized at Exelixis

Suicide attempters with schizophrenia show increased serum S-100B protein levels

CD38 as therapeutic target for protection against doxorubicin-induced cardiotoxicity

Ikena Oncology targets TEAD transcription in cancer with IK-930

BNIP3L is a molecular target in mitophagy defects and mitochondrial dysfunction

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Immusoft and Takeda to jointly develop cell therapies for neurometabolic disorders

Preclinical studies show potential of melanocortin agonists PL-8331 and PL-9654 for ocular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...